1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea

C49H77N7O18S — CID 129045450

IUPAC1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea
SMILESC[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2NC(=O)NNS(=O)(=O)c1ncn[nH]1
InChIInChI=1S/C49H77N7O18S/c1-28-17-15-13-11-9-7-5-6-8-10-12-14-16-18-35(73-46-45(66)41(50)44(65)31(4)72-46)24-39-42(53-47(67)54-56-75(69,70)48-51-27-52-55-48)38(62)26-49(68,74-39)25-34(59)22-37(61)36(60)20-19-32(57)21-33(58)23-40(63)71-30(3)29(2)43(28)64/h5-18,27-39,41-46,56-62,64-66,68H,19-26,50H2,1-4H3,(H,51,52,55)(H2,53,54,67)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t28-,29-,30-,31+,32+,33+,34-,35-,36+,37+,38-,39-,41-,42+,43+,44+,45-,46-,49+/m0/s1
InChIKeyLCXUXFPYUNBCIF-AUJWGOBUSA-N
MW1084.25 g/mol
LogP-1.31
Rot. Bonds6

About 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea

1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea (PubChem CID 129045450) has the molecular formula C49H77N7O18S and a molecular weight of 1084.25 g/mol. Its IUPAC name is 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea.

Molecular Properties

Compound Name1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea
PubChem CID129045450
Molecular FormulaC49H77N7O18S
Molecular Weight1084.25 g/mol
Exact Mass1083.50
IUPAC Name1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea
SMILESC[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2NC(=O)NNS(=O)(=O)c1ncn[nH]1
InChIInChI=1S/C49H77N7O18S/c1-28-17-15-13-11-9-7-5-6-8-10-12-14-16-18-35(73-46-45(66)41(50)44(65)31(4)72-46)24-39-42(53-47(67)54-56-75(69,70)48-51-27-52-55-48)38(62)26-49(68,74-39)25-34(59)22-37(61)36(60)20-19-32(57)21-33(58)23-40(63)71-30(3)29(2)43(28)64/h5-18,27-39,41-46,56-62,64-66,68H,19-26,50H2,1-4H3,(H,51,52,55)(H2,53,54,67)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t28-,29-,30-,31+,32+,33+,34-,35-,36+,37+,38-,39-,41-,42+,43+,44+,45-,46-,49+/m0/s1
InChIKeyLCXUXFPYUNBCIF-AUJWGOBUSA-N
XLogP-1.31
TPSA411.18 Ų
H-Bond Donors15
H-Bond Acceptors21
Rotatable Bonds6
Heavy Atoms75
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001084.25
LogP ≤ 5-1.31
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea?
The IUPAC name of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea (CID 129045450) is 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea.
What is the SMILES notation for 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea?
The canonical SMILES for 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea is C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2NC(=O)NNS(=O)(=O)c1ncn[nH]1.
What is the InChIKey of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea?
The InChIKey is LCXUXFPYUNBCIF-AUJWGOBUSA-N. The full InChI is InChI=1S/C49H77N7O18S/c1-28-17-15-13-11-9-7-5-6-8-10-12-14-16-18-35(73-46-45(66)41(50)44(65)31(4)72-46)24-39-42(53-47(67)54-56-75(69,70)48-51-27-52-55-48)38(62)26-49(68,74-39)25-34(59)22-37(61)36(60)20-19-32(57)21-33(58)23-40(63)71-30(3)29(2)43(28)64/h5-18,27-39,41-46,56-62,64-66,68H,19-26,50H2,1-4H3,(H,51,52,55)(H2,53,54,67)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t28-,29-,30-,31+,32+,33+,34-,35-,36+,37+,38-,39-,41-,42+,43+,44+,45-,46-,49+/m0/s1.
What are the key properties of 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea?
1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea has a molecular weight of 1084.25 g/mol, XLogP of -1.31, 6 rotatable bonds, 15 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-36-yl]-3-(1H-1,2,4-triazol-5-ylsulfonylamino)urea is sourced from PubChem (CID 129045450), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).